Led · Equity · Jan 2026

CryoFuture operates seven fertility-dedicated cryogenic storage facilities across the United States and offers nationwide, ultra-low-temperature transport of biological materials for IVF clinics and patients. The San Mateo-based company was founded by senior embryologist Sean Pae and healthcare executive Cherie Kloss to deliver safer and more convenient long-term preservation of reproductive cells and tissues. Its service model pairs local storage infrastructure with white-glove logistics, aiming to raise the standard for transparency and reliability in cryopreservation. With fresh capital in hand, CryoFuture plans to accelerate national expansion and continue investing in its proprietary cryopreservation technology. Management positions the firm as a category leader capable of meeting growing demand from clinics and patients for secure, mission-critical fertility specimen handling. No revenue or user figures were disclosed in the article, but the company highlights its comprehensive suite of services as a competitive advantage.